Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £4.07m
DSG Live PriceLast checked at - London Stock Exchange

Intraday Dillistone Share Chart

Placing

3 Oct 2014 14:58

RNS Number : 4437T
Dillistone Group PLC
03 October 2014
Ā 



3 October 2014

Ā 

Dillistone Group Plc

("Dillistone", the "Company" or the "Group")

Additional £500,000 placing

Ā 

On 30 September 2014, Dillistone Group Plc, the AIM quoted supplier of software and services for the recruitment sector, announced a placing at 95p per share to raise £500,000 (before expenses) to finance part of the initial cash consideration due in respect of the acquisition of ISV Software Limited.

Ā 

The Company is pleased to announce today that WH Ireland has carried out a further placing on behalf of Dillistone of 526,316 new ordinary shares of 5p each in the share capital of Dillistone ("Placing Shares") to raise, also at a price of 95p per Placing Share, an additional £500,000 (before expenses) which will be used by the Group for working capital purposes.

Ā 

The issue of 263,158 of these Placing Shares, to raise proceeds of £250,000, is conditional only upon admission of such shares to AIM ("Admission"), which is expected to take place by 9 October 2014.

Ā 

The issue of the remaining 263,158 Placing Shares is conditional upon both Admission and also the Company receiving provisional clearance from HMRC that such Placing Shares will be eligible for the purposes of section 285(3A) of the Income Tax Act 2007 and that they will be qualifying holdings for the purposes of Chapter 4, Part 6, Income Tax Act 2007. It is expected that such clearance will be received by 30 November 2014, whereupon the Company will apply for such shares to be admitted to trading on AIM.

Ā 

Dr Mike Love (Chairman) and Mr Jason Starr (Chief Executive) are respectively subscribing for 252,632 and 10,526 Placing Shares. Their participation is regarded as a related party transaction for the purposes of the AIM Rules for Companies. With the exception of Dr. Mike Love and Mr Jason Starr, the directors of the Company consider, having consulted with its nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned. Following the Placing Dr. Mike Love's beneficial holding will be 703,254 Ordinary Shares and Mr Jason Starr's will be 3,564,959 Ordinary Shares.

Ā 

Ā 

Enquiries:

Ā 

Dillistone Group Plc

Ā 

Ā 

Mike Love

Chairman

020 7749 6100

Jason Starr

Chief Executive

020 7749 6100

Julie Pomeroy

Finance Director

020 7749 6100

WH Ireland Limited (Nominated adviser)

Ā 

Ā 

Chris Fielding

Head of Corporate Finance

020 7220 1650

Winningtons

Ā 

Ā 

Tom Cooper / Paul Vann

Ā 

020 3176 4722

Ā 

Ā 

0797 122 1972

tom.cooper@winningtons.co.uk

Ā 

Ā 

Notes to Editors:

Dillistone Group Plc (www.dillistonegroup.com) is a leader in the supply and support of software and services to the recruitment industry. It has four trading businesses operating through two divisions: Dillistone Systems, which targets the executive search industry (www.dillistone.com); and Voyager Software, which targets other recruitment markets (www.voyagersoftware.com).

Dillistone has made three acquisitions: Voyager Software in September 2011, FCP Internet in July 2013 and ISV Software in September 2014. The Group operates under the FileFinder, Infinity, Evolve and ISV brands.

Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc, in June 2006. The Group employs over 100 people globally with offices in London (head office) Basingstoke and Southampton, Frankfurt, New Jersey and Sydney.

Ā 

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
IOEKMMGGFFVGDZM
Date   Source Headline
7th May 20267:00 amRNSFinal Results & Investor Presentation
24th Apr 20267:00 amRNSNotice of Final Results & Investor Presentation
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
2nd Mar 20263:08 pmRNSHolding(s) in Company
25th Feb 202611:40 amRNSHolding(s) in Company
25th Feb 202610:09 amRNSHolding(s) in Company
23rd Feb 20262:28 pmRNSResult of GM & Directorate Change
11th Feb 202612:59 pmRNSHolding(s) in Company
5th Feb 202611:28 amRNSResult of Placing and Subscription
4th Feb 20264:47 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim Results & Investor Presentation
11th Sep 20257:00 amRNSNotice of Interim Results & Investor Presentation
4th Jun 202511:50 amRNSResult of AGM
4th Jun 20257:01 amRNSAGM Statement
4th Jun 20257:00 amRNSRelated party loan
9th May 202511:32 amRNSDirectorate Declaration
8th Apr 20257:00 amRNSFinal Results & Investor Presentation
3rd Apr 20257:00 amRNSNotice of Results & Investor Presentation
5th Feb 20257:00 amRNSTrading Update & Notice of Results
4th Dec 20247:00 amRNS-ROpenAI powered Interview Simulation Platform
17th Sep 20247:00 amRNSInterim Results & Investor Presentation
11th Sep 20247:00 amRNSNotice of Results & Investor Presentation
2nd Sep 20249:45 amRNSHolding(s) in Company
29th Aug 20248:30 amRNSHolding(s) in Company
23rd Aug 20247:00 amRNSTrading update and Fund Raising
15th Jul 20247:00 amRNSChange of Adviser
12th Jun 20241:40 pmRNSResult of AGM
12th Jun 20247:00 amRNSAGM Statement
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.